Filing Details

Accession Number:
0001562180-23-005105
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-13 16:24:55
Reporting Period:
2023-06-09
Accepted Time:
2023-06-13 16:24:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1667011 Arteris Inc. AIP Semiconductors & Related Devices (3674) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1888542 L Paul Alpern C/O Arteris, Inc.
595 Millich Dr., Suite 200
Campbell CA 95008
Vp And General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-09 40,000 $0.60 88,953 No 4 M Direct
Common Stock Disposition 2023-06-09 42,051 $7.33 46,902 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2023-06-09 40,000 $0.00 40,000 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2030-07-22 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $0.56 2029-10-23 200,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-10-23 200,000 200,000 Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. 25% of the total shares shall vest on July 23 2021; thereafter, 1/48th of the total shares shall vest monthly for 3 years. beginning on August 23, 2021.
  3. Includes 46,902 restricted stock units.
  4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.55 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The shares subject to the stock option will vest and become exercisable with respect to 25% of the shares on August 26, 2020 and in 36 substantially equal monthly installments thereafter.